Skip to content

Order of Testing and DNA Preservation

Planning serology and DNA examinations on limited stains, including controls, treatment effects, differential extraction and traceable records.

By Reviewed by Sourabh

Last updated:

An examination plan balances documentation, biological-fluid testing, DNA analysis and material needed for further work. Visual examination often comes first, but there is no universal requirement to complete presumptive and confirmatory serology before DNA extraction. Choose the order using the case questions, sample condition, validated methods and the effects of each treatment.

A biological trace is finite. A cutting, swab or extract used for one test can reduce what remains for other examinations. Serology can help characterise or select material, while DNA analysis addresses genetic contributors. A DNA profile alone does not retrospectively identify the body fluid.

The order of examination should preserve relevant information while avoiding unnecessary consumption. Some tests can share a validated extraction workflow; others need separately reserved material. A plan may change when screening, sample quantity or the investigative question provides new information.

A request such as “Is this stain blood?” differs from “Can this material yield an informative DNA comparison?” A presumptive test can support screening but may not answer the first question conclusively. Clarifying the request helps prevent a limited specimen from being exhausted on tests that do not resolve the relevant issue.

Chemical treatment can affect later examinations through consumption, dilution, redistribution, interference or damage. Effects vary by formulation and method. Document the treatment and assess compatibility rather than assuming every luminol application destroys DNA or that one alternative product is harmless under all conditions.

The practical task is to decide what must be documented, what material to reserve, which examinations to perform and how to communicate the limitations. The plan connects scientific sampling decisions with a traceable record of the exhibit and results.

By the end of this topic you will be able to:

  • Plan documentation, sample selection, fluid examination and DNA work around the case questions.
  • Explain material consumption, treatment effects and the value of appropriate reserves.
  • Interpret positive, negative and inconclusive results within a validated method’s scope.
  • Distinguish differential-extraction fractions from contributor identities.
  • Record observations, controls, treatments, transfers and later amendments transparently.

Related reading: RSID-Blood and ABAcard HemaTrace; Quality Assurance in Serology Laboratories.

Key terms
Sequential testing protocol
A sequential testing protocol specifies an order of examinations intended to preserve relevant information and manage limited material. Its application depends on the case question, specimen and validated procedures. It does not impose one universal requirement to finish serology before DNA extraction.
Non-destructive examination
A non-destructive examination seeks information without consuming or materially altering the relevant evidence. Examples can include visual inspection and suitable imaging. Exposure conditions and handling still require consideration; the label does not establish that every illumination or treatment is harmless.
Destructive testing
Destructive testing consumes material or alters relevant evidence properties, for example through sampling, extraction or chemical reaction. A plan should document the material used, retained reserves and consequences for later examinations. Some extracts or subsamples remain available for compatible further work.
Differential extraction
Differential extraction uses differences in cell lysis and separation to produce sperm-enriched and non-sperm fractions from a suitable sample. Separation may be incomplete, and both fractions can contain multiple contributors. Their labels do not automatically identify a suspect or complainant.
PCR inhibitor
A PCR inhibitor interferes with amplification under the assay conditions and may reduce signal or prevent a result. Blood-derived compounds, substrate contaminants and treatment residues can contribute. Inhibition is distinct from absence of DNA or fragmentation and requires suitable assessment and validated mitigation.
Chain of custody
Chain of custody records relevant collection, possession, transfers, storage and handling of evidence so that its identity and history can be assessed. Technical examination records supply additional detail. A gap requires contextual evaluation rather than an automatic conclusion about contamination or legal admissibility.

Why Test Order Matters for Limited Samples

The central constraint of biological evidence examination is that the original stain is finite and, once tested, partially consumed. A fabric cutting taken for a presumptive test, a swab used for a lateral-flow card, and an extraction plug removed for DNA profiling are all permanent reductions of the original evidence.

Sampling plans balance identification, DNA profiling and material for further examination.

If the available material is exhausted, further testing or independent re-examination may be limited. The plan should identify foreseeable examinations and any retention obligations before destructive work. Whether additional testing is required or permitted depends on the case and applicable procedure.

Documentation and visual examination usually consume little material, while sampling and chemical work can alter an exhibit. Alternate-light exposure also requires suitable conditions and duration. Select representative material and relevant controls instead of assuming the stain edge always supplies the best test sample.

DNA testing can be justified without a prior positive serological result. Conversely, a DNA result may not answer the fluid-identification question. The examination plan should make that distinction explicit and record why a selected portion was tested or reserved.

Stage 1: Presumptive Testing

Presumptive tests provide screening information within their demonstrated detection capability. A positive catalytic blood test does not identify blood conclusively; a negative result does not exclude blood below detection limits, after loss or where interference prevents a valid response. Interpret the result using controls, conditions and the case question.

A validated plan adapts the testing sequence to the case and the amount of evidence.

Luminol and suitable Bluestar formulations can locate traces that are not visible before treatment, so collection cannot always precede the search. Document and sample visible material first where appropriate, then map search responses and collect relevant areas. Neither product name establishes universal DNA compatibility or a requirement for one fixed sequence.

When a search reagent has been used, record the formulation and treatment and communicate them to the receiving analyst. The validated DNA workflow should address relevant compatibility, dilution and possible interference. Do not rinse evidence or add an improvised clean-up step merely because a reagent was applied.

Positive, reagent-negative and relevant substrate controls answer different questions. The applicable procedure specifies their selection, timing and acceptance criteria. A positive control checks response to known target material; a reagent-negative control checks the process without that target; a substrate control can help assess relevant background or interference.

Controls test different possible sources of error; their results accompany the case observation.

Stage 2: Confirmatory Testing

A test supports the identification conclusion demonstrated by its validation. Blood-marker cards differ in targets and tested cross-reactivity. A haemoglobin assay and a glycophorin A assay should not be described as identical, and a device’s result must be interpreted with its extraction, controls and permitted observation conditions.

Microscopy can identify spermatozoa using a suitable stain and morphological criteria. Christmas tree stain ing commonly gives contrasting colours to sperm heads and tails, but preserved structures vary. Finding sperm cells supplies different information from detecting a soluble semen-related protein and does not itself determine the contributor or deposition activity.

Where spermatozoa are not observed, suitable protein assays may still supply useful semen-related evidence. PSA and semenogelin tests target different proteins and have their own specificity limits. Absence of visible sperm does not establish azoospermia, and PSA detection alone should not be treated as unconditional semen confirmation.

Scroll horizontally if needed to see the full table.

QuestionPossible examinationImportant limit
Possible bloodCatalytic screen followed by suitable specific work if neededScreening alone does not identify blood
Sperm cellsValidated microscopyNegative microscopy does not exclude semen-related material
Semen-related proteinAppropriate PSA or semenogelin assayTargets and specificity differ
Saliva-related findingAmylase activity or suitable targeted assayAmylase is not absolutely restricted to saliva
Other fluidsSuitable validated conventional or molecular approachDo not substitute a menstrual assay for vaginal-fluid identification

Stage 3: Species Confirmation

Species interpretation depends on the actual assay. Some haemoglobin-based tests react with other primates or selected non-human species, while glycophorin A assays have different tested specificity. A fluid-related result and a species-related result should each be stated at the level supported by the validated method.

Classical precipitin methods target soluble proteins using suitable antisera. Modern fluid assays instead have their own molecular targets, including salivary amylase, PSA or semenogelin. The species and tissue distribution of the target and the tested cross-reactivity panel determine the information that can be reported.

Species identification can use validated DNA approaches, including sequencing suitable mitochondrial regions such as cytochrome b. Reliable interpretation requires sequence quality, appropriate reference data and consideration of close relatives, mixtures and target coverage. One locus does not resolve every possible species comparison.

DNA Preservation: Practical Precautions at Each Stage

Preservation begins with contamination control, suitable documentation and a plan for the actual specimen. Dry appropriate items and swabs under controlled conditions and use suitable packaging. Portable items, liquids, sharps and trace material can need different handling; the receiving laboratory’s requirements and other evidence types also matter.

Dry items and swabs before packaging; handle liquid reference blood under the collection protocol.
  • Document the exhibit and relevant distribution before alteration where practicable, then collect representative material with contamination controls.
  • Select small appropriate portions for screening; preserve other material where the case and sample allow.
  • Combine serology and DNA extracts only within a demonstrated compatible workflow.
  • Record search-reagent exposure and assess downstream compatibility using validated procedures.
  • Match packaging and storage to dried items, swabs or liquids; control moisture and avoid unnecessary handling or temperature cycling.

Chain-of-Custody Documentation

Handling records connect the exhibit to collection, receipt, storage, sampling and analysis. Different trained personnel can perform serology and DNA work, provided their activities and transfers are traceable. Records should distinguish custody information from technical observations, controls and interpretation.

Record the exhibit and sample location, method, relevant reagent identifiers, observations, interpretation, controls, analyst and dates under the applicable procedure. Sampling notes should describe the material used and retained. Communicate relevant serology findings and treatments with a DNA submission so that later work can be planned and interpreted appropriately.

Contemporaneous records preserve the connection between the item and each analytical result.

ISO/IEC 17025 distinguishes validation, verification and technical-record requirements within a defined laboratory scope. Accreditation and legal disclosure are separate matters. US rules, the relevant UK legal system, India’s BSA and other jurisdictions have their own evidential and procedural frameworks; none should be treated as prescribing one worldwide serology sequence.

Special Cases: Sexual Assault and Mixed Samples

Sexual-assault samples can contain sperm cells, non-sperm cells and extracellular DNA from more than one person. Differential extraction exploits differences in susceptibility to lysis to produce enriched fractions. The fraction labels describe a laboratory process, not an automatic assignment to a complainant, suspect or single contributor.

A conventional differential extraction first releases DNA from more readily lysed cells while retaining suitable sperm cells, then uses additional treatment, often including a reducing agent such as DTT, to release sperm-associated DNA. The actual buffers, separation, washing and recovery steps require a validated procedure.

Differential extraction enriches cell fractions; either fraction can still contain DNA from more than one contributor.

Microscopy can help document sperm cells, but its timing depends on the validated workflow. For example, the FBI procedure includes examination of material from a differential-extraction fraction. A negative microscopic result and a protein result require separate interpretation; neither automatically determines one mandatory extraction pathway.

  1. Use fluid-related screening where it answers a relevant question and preserves suitable material.
  2. Assess spermatozoa microscopically using the validated workflow, which determines preparation and timing.
  3. Interpret negative microscopy separately from PSA, semenogelin or other marker findings.
  4. Select differential or other extraction according to the sample and validated procedure.
  5. Evaluate profiles from all fractions without assuming that either is pure or belongs to a predetermined person.

Check Your Understanding

Question 1 of 4· 0 answered
What should guide the order of examinations on a limited biological trace?

Sources

  1. 1.FBI screening procedure and interpretation limits
  2. 2.FBI sperm-cell microscopy procedure
  3. 3.NIST differential lysis and extraction
  4. 4.NIST biological-evidence preservation guidance
  5. 5.RSID-Semen target information

Test yourself on Forensic Serology with free, timed mocks.

Practice Forensic Serology questions

Found this useful? Pass it along.